Tourette Syndrome Funding – FY19

Dear Chapter and Support Group Leaders & TAA Members-

It is the time to request support from your Members of Congress for the continued funding at the enacted level of the CDC Tourette Syndrome Public Health Education and Research Program.  This is in addition to any take action letters sent since it goes directly to the staff person who advises your Representative on which programs to support.  Chapter/Support group leaders should send emails to all of the below on behalf of their state chapter/support group.    Please also forward to your chapter/support group members and have everyone ask their family and friends to send emails!!!!  The below list is of key Members of Congress for us to contact in your state.

Individual TAA members should email their Representative’s staff.  If you do not know who your Representative is, please take a moment and go to enter your zip code in the top right corner to find your member.  Once you have your Representative, please find their name below and cut and paste the listed/corresponding draft email text Word Document into the body of an email, add the name of the staff to the top of the email, personalize the email with your/your family’s story about Tourette Syndrome, attach the Dear Colleague letter document titled “Tourette Syndrome Funding – FY19” and send the email to the staff email provided.  If they are not listed below, please go to to send a form letter.

For the following Members of Congress, cut and paste the text from  the attached Word document “Draft Email Dear Colleague” into your email, personalize (your story, staff name and staff email in to:), and remember to attach the “Tourette Syndrome Funding – FY19” document to the email and send to the below staff:

Rep. Ted Poe R-2-TX – Tim Tarpley –

Rep. Kevin Brady R-8-TX  - John Porter – and

Rep. Al Green D-9-TX – Matthew Rowland –

Rep. Randy Weber R-14-TX- Tom Harvey –

Rep. Bill Flores R-17-TX – Eric Gustafson – and Christopher Taylor –

Rep. Jodey Arrington R-19-TX – Elissa McLerran –

Rep. Lamar Smith R-21-TX – Abby Gunderson-Schwarz –

Rep. Pete Olson R-22-TX – Richard England –

Rep. Michael Burgess R-26-TX – Edward Kim – and Elizabeth Allen –

Rep. Pete Sessions R-32-TX – Ron Donado –

Rep. Marc Veasey D-33-TX – Nicole Varner –

Rep. Lloyd Doggett D-35-TX – Afton Cissell –

Rep. Brian Babin R-36-TX – Ben Couhig –

For the following Appropriator Member of Congress, cut and paste the text from “Draft Email Appropriator...” into your email, personalize (your story, staff name and staff email in to:), and remember to attach the “Tourette Syndrome Funding – FY19” document to the email and send to the below staff:

Rep. John Culberson R-7-TX – Corey Inglee – and Hayden Jewett –

Rep. Kay Granger R-12-TX – Suzi Plasencia –

Rep. Henry Cuellar D-28-TX – Juan Sanchez –

If you have any questions, please do not hesitate to contact me.  We have received feedback from staff that these emails really make a difference and appreciate you taking the time to send them.

Best Regards,


Diana Felner

Vice President, Public Policy

Tourette Association of America

P.O. Box 75560

Washington, DC  20013

718.224.2999 ext 202

Mobile 703.966.5551


embed Block
Add an embed URL or code. Learn more



If you are still waiting a form, please send anything else you have NOW. SCAN and email to or FAX to 281-238-0468.

If we have nothing from you by end of day, we CANNOT accept any new apps.


GIRL apps will also close soon, so please get your information IN!


Camp du Ballon Rouge

Camp dBR will be held Friday, March 2 thru Sunday, March 4.  

Applications are NOW AVAILABLE for download on the Camp Page.  

Please complete the app in its entirety!  Be SURE to include/update your email address.

Attend the 2018 TOURETTE GALA

The 2018 Tourette Association -  Texas Chapter Gala Tiaras & Top Hats" will be held Thursday, January 25, 2018 at the beautiful Houston Country Club (#1 Potomac Drive).   Guests will be treated to an evening of reception, dinner, entertainment and live and silent auction.  

Chaired by Stacee and Michael Howse, the annual fundraising event this year honors Joanna and Brad Marks.  

Tables of Ten start at $2,000 and individual tickets start at $200.  For more information, contact Tourette Texas at  or 281-238-8096.




 Dr. Joseph Jankovic, Professor of Neurology and Director of the Movement Disorders Clinic at Baylor College of Medicine, and his team at Baylor are currently enrolling patients into two studies designed to improve tics and other symptoms associated with Tourette syndrome (TS).

1.      Valbenazine (also known as NBI-98854 and Ingrezza), already approved by the Food and Drug Administration (FDA) for the treatment of tardive dyskinesia, a condition caused by exposure to various drugs used for psychiatric and gastrointestinal disorders, may be beneficial in patients with TS. Patients, 6 to 17 years of age, with established diagnosis of TS may be able to participate in this placebo-controlled study.

2.         Deutetrabenazine (also known as SD-809 and Austedo), already approved by the FDA for the treatment of Huntington disease and tardive dyskinesia, is another drug studied at Baylor.  TS children, 6 to16 years old, with troublesome tics may be eligible to participate in this double-blind, placebo-controlled, trial.

  Once patients are enrolled in one of these clinical trials there is no cost to them for the drugs, visits or laboratory tests used to monitor the drugs.

"Double-blind, placebo controlled" trial simply means that some patients are randomly selected to receive the active (real) drug and others receive an inactive (placebo) drug.  Neither the patient nor the physician (investigator) will know to which group the patient was assigned (they are both "blind") until the study is completed.  The purpose for this scientific method is to prevent patients or their physicians to be biased about the effects of the drug (good or bad).  Once this phase of the study is completed patients can enroll in an "open-label" phase during which each receives the active drug.

All drugs currently on the market must undergo this type of a trial to be approved by the FDA.  In Europe, instead of using a placebo, the drug companies must select and appropriate a comparator (a drug that already has been approved for the studied condition).

Parents of children who are interested in participating should call 713-798-2273 to make an appointment for initial evaluation or contact Christine Hunter, RN (713-798-3951) or Ami Patel (713-798-6902) for further information.


  The Tourette Association of America - Texas Chapter strongly supports research efforts to alleviate the symptoms of Tourette's and to ultimately find a cure.

  There is no cost for medication, doctor visits or lab tests with these two studies.

  Without such drug trials, we would not have the medications available so necessary for treatment.  However, in these studies your child may or may not receive the medication.  Those that do not (i.e., receive the placebo) will be on no medication to relieve the troublesome symptoms.  Neither the physician nor the patient knows which child receives medication (double-blind study).